New HFSA Scientific Statement Provides Practical Guidance for Managing Heart Failure with Mildly Reduced Ejection Fraction

A new Scientific Statement from the Heart Failure Society of America (HFSA) challenges longstanding ambiguity in the ...
The Cardiology Advisor

Sotatercept May Improve Pulmonary Vascular and Cardiac Hemodynamics in CpcPH–HFpEF

Sotatercept significantly reduces pulmonary vascular resistance in patients with CpcPH–HFpEF compared with placebo, according to a trial.
Seeking Alpha

scPharmaceuticals Announces Positive Type C Meeting Feedback from FDA on Potential Heart Failure Class IV Indication Expansion

BURLINGTON, Mass., Aug. 01, 2023 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to ...
WebMD

Farxiga and Heart Failure: What You Need to Know

The SGLT2 inhibitor medicines have changed how heart failure is managed. Originally sodium-glucose cotransporter 2 (SGLT2) inhibitors were used to lower blood sugar levels in people who have type 2 ...
The American Journal of Managed Care

Heart Failure With Reduced Ejection Fraction: Clinical and Economic Burden and Insights into Current and Emerging Treatments

Heart failure (HF) imposes a large and growing burden on the population, with a prevalence that is projected to increase to more than 8 million adults by 2030. The high risk of morbidity and mortality ...
WebMD

Preventing Heart Failure Complications With Entresto

Some people with heart failure need to take multiple medicines each day in order to keep their symptoms under control. Heart failure not only leads to issues in the heart but other organs in the body ...